ULUSLARARASI YAYINLAR

1) The use of   memantine in drug-resistant dyskinesias due to L-dopa. H.A. Hanağası, G. Kaptanoğlu, HA. Şahin, M. Emre. Movement Disorders 2000; 15(5): 1016-1017.

2) Neuronal intranuclear inclusion disease and juvenile parkinsonism. O’Sullivan, HA. Hanağası, SE. Daniel, P. Tidswell, SW. Davies, AJ. Lees. Movement Disorders 2000; 15(5): 990-995.

3) Evidence-based pharmacological treatment of dementia: a review. M. Emre, HA. Hanağası. European Journal of Neurology 2000; 7(3): 247-253.

4) Intravenous apomorphine therapy in Parkinson’s disease-clinical and pharmacokinetic

observations. JD. Manson, HA Hanağası, K Turner, PN Patsalos, P. Carey, N Ratnaraj, AJ. Lees. Brain-2001; 124: 331-340.

5) Atypical neurolocigal involvement associated with celiac disease. HA Hanağası,  E. Gürol, HA. Şahin, M Emre,

European Journal of Neurology- 2001; 8: 67-69.

6) Do unilateral ablative lesions of the subthalamic nucleus in parkinsonian patients

lead to hemiballism? O. Barlas, HA. Hanağası, M. İmer, HA. Şahin, S. Sencer, M. Emre. Movement Disorders-2001; 16(2): 306-310.

7) Stiff leg syndrome  – case report. E. Gürol, M. Ertaş, HA Hanağası, HA Şahin, M. Emre. Movement Disorders-2001; 16(6): 1189-1193.

8) Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff’s Disease. H. Şahin, İH Gürvit, B. Bilgiç B, HA Hanağası , M. Emre. Clin Neuropharmacol 2002; 25(1):16-20.

9) Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials. HA. Hanağası, İH Gürvit, N. Ermutlu, G. Kaptanoğlu, S. Karamürsel, HA. İdrisoglu, M. Emre, T. Demiralp. Brain Research-Cognitive Brain Research 2002; 14(2): 234-244.

10) Risk factors for Alzheimer disease: a population-based case-control study in İstanbul, Turkey. H. Harmancı, M. Emre, H. Gurvit, B. Bilgic, HA. Hanağası, E. Gurol, H. Sahin, S. Tinaz. Alzheimer Dis Assoc Disord. 2003;17:139-45.

11) Clozapine treatment in oromandibular dystonia. HA. Hanağası, B. Bilgiç, H. Gürvit, M. Emre. Clinical Neuropharmacology 2004;27:84-86.

12) Obsessive-compulsive disorder secondary to bilateral frontal damage due to a closed head injury. B. Bilgic, I. Baral-Kulaksızoğlu, HA. Hanağası, M. Şaylan, E. Aykutlu, H. Gürvit, M. Emre. Cognitive and Behavioral Neurology 2004;2:118-120.

13) Unrecognized depression in community-dwelling elderly persons in İstanbul. I. Baral-Kulaksızoğlu, H. Gürvit, A. Polat, H. Harmancı, S. Cakır, HA. Hanağası, B. Bilgic, M. Emre. International Psychogeriatrics 2005;17:303-312.

14) PARK11 is not linked with Parkinson’s disease in European families. J. Prestel, M. Sharma, P. Leitner, A. Zimprich, JR. Vaughan, A. Dürr, V. Bonifati, G. De Michele, HA. Hanağası, M. Farrer, A. Hofer, F. Asmus, G. Volpe, G. Meco, A. Brice, NW. Wood, B. Müller-Myhsok, T. Gasser. European Journal of Human Genetics 2005;13:193-197.

15) Mitochondrial complex I, II/III and IV activities in familial and sporadic Parkinson’s disease.HA.Hanağası, D. Ayribaş, K. Baysal, M. Emre. International Journal of Neuroscience 2005;115:479-493.

16) Treatment of behavioural symptoms and dementia in Parkinson’s disease.HA.Hanağası, M. Emre. Fundamental and Clinical Neuropharmacology 2005;19:133-146.

17) Parkin expression in muscle from three patients with autosomal recessive Parkinson’s disease carrying parkin mutation. P. Serdaroğlu, HA. Hanağası, H. Taşlı, M. Emre. Acta Myologica 2005;24:2-5.

18) Parkin expression in human skeletal muscle. P. Serdaroğlu, H. Taşlı, HA. Hanağası, M. Emre. J Clin Neurosci. 2005;12:928-30.

19) Destructive stereotactic surgery for treatment of dystonia. M. İmer, B. Özeren, S. Karadereler, Z. Yapıcı, B. Omay, HA. Hanağası, M. Eraksoy. Surg Neurol. 2005;64 (Suppl 2):89-94.

20) What is the cause of this woman’s symptoms? HA.Hanağası, M. Emre. Practical Neurology 2005;5:187-188.

21) The attitude of elderly lay people towards the symptoms of dementia. H. Sahin, IH. Gurvit, M. Emre, HA. Hanağası , B. Bilgic, H. Harmancı. International Psychogeriatrics 2006; 18:251-258.

22) The apolipoprotein E (APOE)  genotype in a Turkish population with Alzheimer’s disease. MB. Yokeş, M. Emre, H. Harmancı, H. Gürvit, HA. Hanağası, H. Şahin, B. Bilgiç, AN. Başak. Balkan Journal of Medical Genetics 2005;8:57-63.

23) Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer’s disease. S. Dogru-Abbasoğlu, M. İnceoğlu, H. Parıldar-Karpuzoğlu, HA. Hanağası, B. Karadağ, H. Gürvit, M. Emre. G. Aykaç-Toker, M. Uysal. Neuroscience Letters 2006;404:258-61. 

24) Smoking-responsive juvenile-onset Parkinsonism. HA.Hanagasi, A. Lees, JO. Johnson, A. Singleton, M. Emre. Movement Disorders 2007;1:115-119 

25) Neurosyphilis presenting with status epilepticus.C. Gurses, M. Kurtuncu, J. Jirsch, N. Yesilot, HA. Hanagasi, N. Bebek, B. Baykan, M. Emre, A. Gokyigit, F. Andermann. Epileptic Disord. 2007;9:51-56

26) The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer’s disease. S. Dogru-Abbasoğlu, G. Aykaç-Toker, HA. Hanağası, H. Gürvit, M. Emre. M. Uysal. Neurol Sci 2007;28:31-4.

27) Clinical and magnetic resonance imaging findings of HIV-Negative patients with neurosyphilis. C. Gurses, B. Bilgic, B. Topcular, OG. Tuncer, G. Akman-Demir, HA. Hanağası, B. Baslo, H. Gurvit, O. Coban, M. Emre, HA. Idrisoglu. J Neurol. 2007;254:368-374.

28) Association between Vitamin D Receptor Gene Polymorphism and Alzheimer’s Disease. D. Gezen-Ak D, E. Dursun E, T. Ertan T, HA. Hanağası, H. Gürvit, M. Emre, E. Eker, M. Oztürk, F. Engin, S. Yilmazer. Tohoku J Exp Med. 2007;212:275-82.

29) Subclinical Impairment of Neuromuscular Transmission in Transient Global Amnesia. M. Ertas, H. Bolay, E. Kocasoy-Orhan, HA. Hanağası , B. Baykan. Cogn Behav Neurol. 2007;20:179-183

30) Presenilin-1 Gene Intronic Polymorphism and Late-onset Alzheimer’s Disease. Dursun, D. Gezen-Ak, T. Ertan, HA. Hanağası, H. Gürvit, M. Emre, E. Eker, M. Oztürk, F. Engin, S. Yilmazer. Journal of Geriatric Psychiatry and Neurology 2008;21:268-73.

31) The prevalence of dementia in an urban Turkish population. İH. Gurvit, M. Emre, S. Tinaz, B. Bilgic, HA. Hanağası, H. Sahin, E. Gurol, JT. Kvaloy, H. Harmanci. Am J Alzheimers Dis Other Demen. 2008;23:67-76.

32) Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer’s disease. I. Parıldar-Karpuzoğlu, S. Doğru-Abbasoğlu, HA. Hanağası, B. Karadağ, H.Gürvit, M. Emre, M. Uysal. Neurosci Lett. 2008;442:287-91.

33) Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson’s disease. Çoban, HA. Hanağası, S. Karamürsel, O. Barlas. Br J Neurosurg. 2009;23:23-9.

34) The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer’s disease. Vural, S. Değirmencioğlu, H. Parıldar-Karpuzoğlu, S. Doğru-Abbasoğlu, HA. Hanağası, B. Karadağ, H Gürvit, M. Emre, M. Uysal. Acta Neurol Scand. 2009;120:396-401.

35) Mitochondrial pathology in muscle of a patient with a novel parkin mutation. HA. Hanağası, P. Serdaroglu, M. Ozansoy, N. Basak,  Hatice Tasli, M. Emre. International Journal of Neuroscience, 2009;119:1572 – 1583.

36) Iatrogenic Botulism After Botulinum Toxin Type A Injections. Çoban A, Z. Matur, HA. Hanağası,Y. Parman. Clin Neuropharmacol. 2010 May;33(3):158-60.

37) An unusual late presentation of subacute sclerosing panencephalitis with psychotic symptoms. Baran, HA. Hanağası,A. Uçok. J Neuropsychiatry Clin Neurosci. 2010;22(1):123.

38) Early-Onset L-dopa-Responsive Parkinsonism withPyramidal Signs Due to ATP13A2, PLA2G6, FBXO7 and Spatacsin Mutations. Paisán-Ruiz, R. Guevara, M. Federoff, HA. Hanağası,F. Sina, E. Elahi, SA. Schneider, P. Schwingenschuh, N. Bajaj, M. Emre, AB. Singleton, J. Hardy, KP. Bhatia, S. Brandner, AJ. Lees, H. Houlden. Mov Disord. 2010; 25:1791-1800.

39) Pain is common in Parkinson’s disease. HA.Hanağası, S. Akat, H. Gurvit, J. Yazici, M. Emre, Clinical Neurology and Neurosurgery 2011;113:11-3.

40) The effects of rasagiline on cognitive deficits in Parkinson’s disease patients without dementia: A randomized, double-blind, placebo-controlled, multi-center study. HA.Hanağası, H. Gurvit, P. Unsalan, H. Horozoglu, N. Tuncer, A. Feyzioglu, DI. Gunal, GG. Yener, R. Cakmur, HA. Sahin, M. Emre. Mov Disord. 2011; 26: 1851–1858.

41) Erdheim Chester disease presenting as slowly progressive cerebellar syndrome and asymptomatic widespread skeletal involvement. Tufan, B. Myftiu, D. Aygun, N. Keles, J. Haroche, HA. Hanağası, H. Gurvit, M. Emre, S. Besisik. Eur J Neurol. 2011;18(8):93.

42) LRRK2 mutations are uncommon in Turkey. HA.Hanağası, E. Lohmann, B. Dursun, A. Honoré, S. Lesage, O. Dogu, H. Kaleagasi, O. Aydın, H. Gürvit, N. Erginel-Unaltuna, A. Brice, M Emre. Eur J Neurol. 2011;18(10):137.

43) The Impact of Familial Structure on Parkinson’s Disease in Istanbul Medical School, Turkey. E Lohmann, HA. Hanağası, H. Gürvit, G. Kayacı, M. Ruberg, J. Yazıcı, M. Emre. Int J Neurosci. 2012;122:102-5.

44) A homozygous frameshift mutation of sepiapterin reductase gene causing parkinsonism with onset in childhood. E Lohmann, C Köroğlu, HA. Hanağası, B. Dursun, E. Taşan E, A. Tolun.Parkinsonism Relat Disord. 2012 ;18:191-3.

45) Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population. E Lohmann, B. Dursun, S. Lesage, HA. Hanağası, G. Kayacı, A. Honoré, B. Bilgiç, O. Dogu, H. Kaleagasi, G. Babacan, J. Yazıcı, H. Gürvit, N. Erginel-Unaltuna, A. Brice, M Emre. Eur J Neurol. 2012 May;19(5):769-775.

46) Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer’s disease. Guerreiro, E. Lohmann, E. Kinsella, JM. Brás, N. Luu, N. Gurunlian, B. Dursun, B. Bilgic, I. Santana, HA. Hanağası, H. Gurvi, JR. Gibbs, C. Oliveira, M. Emre, A. Singleton. Neurobiology of Aging 2012 May;33(5):1008.e17-23.

47) Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method. B. Bilgiç, A.Bayram, AB Arslan, HA. Hanağası, B. Dursun, H. Gurvit, M. Emre, E. Lohmann. Parkinsonism Relat Disord. 2012;18:562-6.

48) Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. E Lohmann, RJ. Guerreiro, N. Erginel-Unaltuna, N. Gurunlian, B. Bilgic, H. Gurvit, HA. Hanağası, N. Luu, M. Emre, A. Singleton. Neurobiol Aging. 2012; 33:1850.e17-27.

49) Dementia and behavioral neurology: recent advances. Bilgic B, HA. Hanağası, M. Emre. J Neurol. 2012;259:1006-10.

50) Dementia and behavioral neurology: recent advances. Bilgic B, HA. Hanağası, M. Emre. J Neurol. 2012;259:1006-10.

51) Vitamin d receptor gene haplotype is associated with late-onset Alzheimer’s disease. Gezen-Ak, E. Dursun, B. Bilgiç, HA. Hanağası, T. Ertan, H. Gürvit, M. Emre, E. Eker, T. Ulutin, O. Uysal, S. Yilmazer. Tohoku J Exp Med. 2012;228(3):189-96.

52) Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia-like Syndrome Without Bone Involvement. Guerreiro, E. Lohmann, JM. Brás, JR. Gibbs, JD. Rohrer, N. Gurunlian, B. Dursun, B. Bilgic, HA. Hanağası, H. Gurvit, M. Emre, A. Singleton, J. Hardy. JAMA Neurol.  2013;70:78-84.

53) Pure gait disturbance displayed by malingerers: Case report of two patients. Benbir, F. Hanağası, S. Ertan, HA.Hanağası, T. Ertan. Clin Neurol Neurosurg. 2013 Jul;115(7):1177-9.

54) A rare dementing disease: adult neuronal ceroid lipofuscinoses. Babacan-Yildiz, HA. Hanağası, H. Gurvit, G. Şirin, S. Solakoglu, OS Kucuk. J Neuropsychiatry Clin Neurosci. 2012;24(4):493-8.

55) Silent neurological involvement in biopsy-defined coeliac patients. B. Bilgiç, D. Aygun, AB.Arslan, A. Bayram, F. Akyuz,  S. Sencer, HA.Hanağası. Neurol Sci 2013: 34(12):2199-204.

56) Reduced Orexin-A Levels in Frontotemporal Dementia: Possible Association With Sleep Disturbance. Coban A, B. Bilgiç, E. Lohmann, CI Küçükali, G. Benbir, D. Karadeniz, HA. Hanağası, E. Tüzün, H. Gurvit. Am J Alzheimers Dis Other Demen. 2013;28(6):606-11

57) Non-Convulsive Status Epilepticus Associated With Glutamic Acid Decarboxylase Antibody. U. Çikrikçili, C. Ulusoy, S. Turan, S. Yildiz, B. Bilgiç, HA. Hanağası, B. Baykan, E. Tüzün, H. Gürvit. Clin EEG Neurosci 2013 44: 232-236

58) A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family. Guerreiro, B. Bilgic, G. Guven, J. Brás, J. Rohrer, E. Lohmann, HA. Hanağası, H. Gurvit, M. Emre. Neurobiol Aging. 2013 34(12):2890.

59) BDNF, TNFα, HSP90, CFH, and IL-10 Serum Levels in Patients with Early or Late Onset Alzheimer’s Disease or Mild Cognitive Impairment. Gezen-Ak, E. Dursun, HA. Hanağası, B. Bilgiç, E. Lohman, OS. Arz, I. Atasoy, M. Alaylıoğlu, B. Onal, H. Gürvit,, S. Yilmazer. J Alzheimers Dis. 2013 Jul 3. [Epub ahead of print]

60) Neuroimaging, Biomarkers, and Management of Dementia with Lewy Bodies. HA.Hanağası, B. Bilgiç, M. Emre. Front Neurol. 2013 Oct 7;4:151

61) Orolingual dyskinesia and involuntary neck movements caused by phenytoin intoxication. Gunduz,E. Kocasoy-Orhan, HA. Hanağası. J Neuropsychiatry Clin Neurosci. 2013 Oct 1;25(4):E51.

62) Evaluation of Incidence and Clinical Features of Antibody-Associated Autoimmune Encephalitis Mimicking Dementia. A.Çoban, Cİ. Küçükali, B. Bilgiç, N. Yalçınkaya, H. Haytural, C. Ulusoy, S. Turan, S. Çakır, A. Üçok, H. Ünübol, HA. Hanağası, H. Gürvit, E. Tüzün. Behavioural Neurology   2014 (2014), Article ID 935379.

63) A. Gündüz, AG. Eken,B.  Bilgiç, HA.  Hanagası, K. Bilgüvar, M. Günel, AN. Başak, S. Ertan. FBXO7-R498X mutation: Phenotypic variability from chorea to early onset parkinsonism within a family. Parkinsonism Relat Disord. 2014 Aug 14. pii: S1353-8020(14)00300-9. doi: 10.1016/j.parkreldis.2014.07.016. [Epub ahead of print]

64) Prevalence of Parkinson’s disease in Baskale, Turkey: a population based study. H. Durmuş, MA. Gökalp,  HA.  Hanagası. Neurol Sci. 2015;36(3):411-3.

65) The distinct genetic pattern of ALS in Turkey and novel mutations. A. Özoğuz, Ö. Uyan, G. Birdal, C. Iskender, E. Kartal, S. Lahut, Ö. Ömür, ZS. Agim, AG. Eken, NE. Sen, P. Kavak, C. Saygı, PC. Sapp, P. Keagle, Y. Parman, E. Tan, F. Koç, F. Deymeer, P. Oflazer P, HA.  Hanagası, H. Gürvit, B. Bilgiç, H. Durmuş, M. Ertaş, D. Kotan, MA. Akalın, H. Güllüoğlu, M. Zarifoğlu, F. Aysal, N. Döşoğlu, K. Bilguvar, M. Günel, Ö. Keskin, T. Akgün, H. Özçelik, JE. Landers, RH. Brown, AN. Başak. Neurobiol Aging. 2015 2015 Apr;36(4):1764.e9-1764.e18.

66) Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation. HA.  Hanagası, B. Bilgiç, TE. Abbink, F. Hanagasi, Z. Tüfekçioğlu, H. Gürvit, N. Başak, MS. van der Knaap, M. Emre. Parkinsonism Relat Disord. 2015;5:544-546.

67) Clinical variability in ataxia-telangiectasia. E. Lohmann, S. Krüger, AK. Hauser,  HA.  Hanagası, G. Guven, N. Erginel-Unaltuna, Biskup S, Gasser T. J Neurol. 2015 May 10. [Epub ahead of print]

68) The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer’s disease, mild cognitive impairment or Parkinson’s disease. E. Dursun, D. Gezen-Ak,  HA.  Hanagası, B. Bilgiç, E. Lohmann, S. Ertan, İL.Atasoy, M. Alaylıoğlu M, ÖS. Araz, B. Önal, A. Gündüz, H. Apaydın, G. Kızıltan, T. Ulutin, H. Gürvit, Yılmazer S.J Neuroimmunol. 2015 Jun 15;283:50-7.

69) A new F-box protein 7 gene mutation causing typical Parkinson’s disease. E. Lohmann, AS. Coquel, A. Honoré, H. Gurvit,  HA.  Hanagası, M. Emre, AL. Leutenegger, V. Drouet, M. Sahbatou, G. Guven, N. Erginel-Unaltuna, JF. Deleuze, S. Lesage, A. Brice. Mov Disord. 2015 May 23. doi: 10.1002/mds.26266.

70) NMDA Receptor Encephalitis with Cancer of Unknown Primary Origin Ref.: Ms. No. TJ-D-15-00375R1 Accepted for publication in Tumori Journal.